go back

Oklahoma rates for HCPCS Q2055

Idecabtagene vicleucel, up to 510 million autologous B-cell maturation antigen (BCMA) directed CAR-positive T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $42,658 · 10th–90th $23,988–$660,6930%10%10th90th$42,658Professionalmedian $562,341 · 10th–90th $562,341–$776,2470%50%90th$562,341$20.0K$50.0K$100.0K$200.0K$500.0K$1.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$562,341.33 / $602,559.59 / $851,138.04
Aetna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $776,247.12
BCBS
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$22,387.21 / $34,673.69 / $57,543.99
Medica
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$537,031.80 / $562,341.33 / $954,992.59
United
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $870,963.59
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$524,807.46 / $524,807.46 / $588,843.66